{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:16Z","timestamp":1789907656771,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T00:00:00Z","timestamp":1405468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s11060-014-1523-1","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T16:34:45Z","timestamp":1405442085000},"page":"111-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analyzing temozolomide medication errors: potentially fatal"],"prefix":"10.1007","volume":"120","author":[{"given":"Nathalie","family":"Letarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"Bressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Stachnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lee","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,16]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","volume":"17","author":"WK Yung","year":"1999","unstructured":"Yung WK, Prados MD, Yaya-Tur R et al (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17:2762\u20132771","journal-title":"J Clin Oncol"},{"key":"1523_CR2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC\u2013NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol."},{"key":"1523_CR3","unstructured":"MERCK & CO. INC. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/t\/temodar_capsules\/temodar_pi.pdf . Accessed 20 Apr 2014"},{"key":"1523_CR4","first-page":"42","volume":"7","author":"J Phillips","year":"2003","unstructured":"Phillips J (2003) FDA Safety page: fatal medication errors associated with Temodar. Drug Topics 7:42","journal-title":"Drug Topics."},{"key":"1523_CR5","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.25027","volume":"116","author":"SN Weingart","year":"2010","unstructured":"Weingart SN, Toro J, Spencer J et al (2010) Medication errors involving oral chemotherapy. Cancer 116:2455\u20132464","journal-title":"Cancer"},{"key":"1523_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/JOP.2010.000064","volume":"7","author":"SN Weingart","year":"2011","unstructured":"Weingart SN, Spencer J, Buia S et al (2011) Medication safety of five oral chemotherapies: a proactive risk assessment. J Oncol Pract 7:2\u20136","journal-title":"J Oncol Pract."},{"key":"1523_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00280-011-1679-8","volume":"69","author":"JL Villano","year":"2012","unstructured":"Villano JL, Letarte N, Yu JM, Abdur S, Bressler LR (2012) Hematologic adverse events associated with temozolomide. Cancer Chemother Pharmacol 69:107\u2013113","journal-title":"Cancer Chemother Pharmacol"},{"key":"1523_CR8","unstructured":"National Coordinating Council for Medication Error Reporting and Prevention. About medication errors. http:\/\/www.nccmerp.org . Accessed 16 Apr 2014"},{"key":"1523_CR9","unstructured":"ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents. Medication misadventures, guidelines. American Society of Health-System Pharmacists. http:\/\/www.ashp.org . Accessed 16 Apr 2014"},{"key":"1523_CR10","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.293.17.2131","volume":"293","author":"CL Bennett","year":"2005","unstructured":"Bennett CL, Nebeker JR, Lyons EA et al (2005) The Research on Adverse Drug Events and Reports (RADAR) project. JAMA 293:2131\u20132140","journal-title":"JAMA"},{"key":"1523_CR11","doi-asserted-by":"crossref","unstructured":"Cooper MA, Ibrahim A, Lyu H, Makary MA (2013) Underreporting of robotic surgery complications. J Healthc Qual doi: 10.1111\/jhq.12036","DOI":"10.1111\/jhq.12036"},{"key":"1523_CR12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","volume":"107","author":"M Koshy","year":"2012","unstructured":"Koshy M, Villano JL, Dolecek TA et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107:207\u2013212","journal-title":"J Neurooncol"},{"issue":"Suppl 2","key":"1523_CR13","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","volume":"15","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro Oncol 15(Suppl 2):ii1\u2013ii56","journal-title":"Neuro Oncol."},{"key":"1523_CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ctrv.2012.06.002","volume":"39","author":"Z Tatar","year":"2013","unstructured":"Tatar Z, Thivat E, Planchat E et al (2013) Temozolomide and unusual indications: review of literature. Cancer Treat Rev 39:125\u2013135","journal-title":"Cancer Treat Rev"},{"key":"1523_CR15","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1200\/JOP.2012.000677","volume":"8","author":"SN Weingart","year":"2012","unstructured":"Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M (2012) Improving electronic oral chemotherapy prescription: can we build a safer system? J Oncol Pract 8:e168\u2013e173","journal-title":"J Oncol Pract."},{"key":"1523_CR16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2354.2009.01127.x","volume":"19","author":"DL Schwappach","year":"2010","unstructured":"Schwappach DL, Wernli M (2010) Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care (Engl) 19:285\u2013292","journal-title":"Eur J Cancer Care (Engl)."},{"key":"1523_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/annonc\/mdq346","volume":"22","author":"DL Schwappach","year":"2011","unstructured":"Schwappach DL, Wernli M (2011) Barriers and facilitators to chemotherapy patients\u2019 engagement in medical error prevention. Ann Oncol 22:424\u2013430","journal-title":"Ann Oncol"},{"key":"1523_CR18","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/cncr.22131","volume":"107","author":"JA Taylor","year":"2006","unstructured":"Taylor JA, Winter L, Geyer LJ, Hawkins DS (2006) Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer 107:1400\u20131406","journal-title":"Cancer"},{"key":"1523_CR19","unstructured":"A Call to Action: Protecting U.S. citizens from inappropriate medication use. http:\/\/www.ismp.org\/pressroom\/viewpoints\/CommunityPharmacy.pdf (serial online) Accessed 28 Apr 2014"},{"key":"1523_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JOP.2.1.5","volume":"2","author":"AM Birner","year":"2006","unstructured":"Birner AM, Bedell MK, Avery JT, Ernstoff MS (2006) Program to support safe administration of oral chemotherapy. J Oncol Pract 2:5\u20136","journal-title":"J Oncol Pract."},{"key":"1523_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/NCC.0b013e3182551587","volume":"36","author":"SL Spoelstra","year":"2013","unstructured":"Spoelstra SL, Given BA, Given CW et al (2013) An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory study. Cancer Nurs 36:18\u201328","journal-title":"Cancer Nurs"},{"key":"1523_CR22","unstructured":"MASCC teaching tool for patients receiving oral agents for cancer. http:\/\/www.mascc.org\/assets\/documents\/MOATT_English_2010.pdf (serial online) Accessed 28 Apr 2014"},{"key":"1523_CR23","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/JOP.2013.000874","volume":"9","author":"MN Neuss","year":"2013","unstructured":"Neuss MN, Polovich M, McNiff K et al (2013) 2013 updated american society of clinical oncology\/oncology nursing society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract 9:5s\u201313s","journal-title":"J Oncol Pract."},{"key":"1523_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1369-7625.2011.00755.x","volume":"17","author":"DL Schwappach","year":"2014","unstructured":"Schwappach DL. (2014) Risk factors for patient-reported medical errors in eleven countries. Health Expect 17:321\u2013331","journal-title":"Health Expect"},{"key":"1523_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JOP.200031","volume":"6","author":"A Jatoi","year":"2010","unstructured":"Jatoi A, Smith EL, Gunderson HD et al (2010) Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy. J Oncol Pract 6:210\u2013212","journal-title":"J Oncol Pract."}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1523-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-014-1523-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1523-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T05:56:59Z","timestamp":1717048619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-014-1523-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1007\/s11060-014-1523-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,16]]}}}